Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseLife at Premier By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Clinical ResearchPhase 1 - Phase 4 Six Insights To Treating Fibromyalgia By Scott Millard July 14, 2017 Clinical ResearchPhase 1 - Phase 4 The Pathogenesis of Acne and What It Means for Drug Developers By Premier Research July 13, 2017 Clinical ResearchPhase 1 - Phase 4 Target Product Profiles: Turning Discoveries into Companies By Premier Research July 12, 2017 Consulting Rushing Site Selection in Fibromyalgia Trials, Not a Great Idea By Scott Millard July 7, 2017 Clinical ResearchPhase 1 - Phase 4 8 Steps to Jump-Starting a CEC By Premier Research July 6, 2017 Clinical ResearchPhase 1 - Phase 4 The Top 5 Concerns for Pediatric Study Participants By Angi Robinson July 5, 2017 Previous 1 …43 44 45 46 47 … 57 Next × ALSO OF INTERESTKey Considerations When Designing a Phase 1...Nostalgia or Shell Shock? Assessing PTSD Is a...Gene Therapy 101: From the 1960s to Today